BN Business News
Add your company to Business Communicator →

Business · 07/11/2011

FDA Releases Draft Guidance for In Vitro Diagnostic Devices for Yersinia Species Detection

The Food and Drug Administration (FDA) has made available a draft guidance document outlining the special controls for Class II in vitro diagnostic devices used to detect Yersinia species, a step towards ensuring compliance with FDA regulations.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights